MedTrace Logo

IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism

NCT02713581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2020-06-30

No results posted yet for this study

Summary

The primary objective of this study is to search for, in vitro, elements associated with IgG-dependent monocyte activation (signaling pathway activation, expression of pro-coagulant and pro-inflammatory factors) and to describe their prevalence in female patients with a history of proximal venous thromboembolism (proximal deep vein thrombosis or pulmonary embolism) compared to control women.

Conditions

Interventions

BIOLOGICAL

Blood sampling

Venous blood will be sampled for laboratory analyses (see outcomes).

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Sylvie Bouvier, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-03
Primary Completion
2019-01-03
Completion
2020-06-23

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02713581 on ClinicalTrials.gov